Giving a strong recommendation for HPV vaccination at age 9 will increase vaccine completion success and prevent more cancers.

Healthcare providers should start the 2-dose series at the age 9 well visit. Starting the vaccine series and the conversation about HPV vaccination at age 9 will increase the success of completing the series by age 13.

Giving a strong recommendation at age 9 will increase vaccination success. Starting at age 9 gives health providers time to complete the HPV series before age 11 when they need to get the Tdap and MenACWY vaccines.

The Advisory Committee on Immunization Practices (ACIP) and the Centers for Disease Control and Prevention (CDC) support vaccination starting at age 9. The ACIP, the CDC, the American Academy of Pediatrics (AAP), the American Cancer Society (ACS), and the National HPV Vaccination Roundtable all agree that HPV vaccination can start at age 9.

View our Call to Action Letter!

HPVRT Why Age 9? Fact Sheet

Video: HPV Vaccinations: 9 Benefits to starting at age 9

Start at Age 9: Print-On-Demand Toolkit

Take these communications actions to help normalize HPV vaccination at age 9.


View the core messages that you can use to share the “Start at 9” messages.


Download a communications toolbox for your organization to update your messages on your website, in print, and through social channels. Each toolbox has a checklist of actions to get started and social posts, eNews blurbs, and prewritten email copy.


Share social messages from the National HPV Vaccination Roundtable all summer long to boost HPV vaccination rates.


JOIN our HPV Roundtable e-newsletter list to get additional resources to help you increase HPV vaccination. Make plans to join online for the 2022 National Meeting on September 28! 


Useful Resources

Here are some useful resources to support “Start at 9” messages: